Histological differentiation in human breast cancer is related to steroid receptors and stromal elastosis Pierre Henri RollandJocelyne JacquemierPierre Marie Martin Original Articles Pages: 73 - 77
Comparative toxicity of detorubicin and doxorubicin, free and DNA-bound, for hemopoietic stem cells Michel HuybrechtsAndré Trouet Original Articles Pages: 79 - 82
Deoxycoformycin toxicity in mice after long-term treatment Ram P. Agarwal Original Articles Pages: 83 - 87
Amphotericin B plus combination chemotherapy for extensive non-small cell bronchogenic carcinoma Gregory SarnaBarry B. LowitzMartin J. Cline Original Articles Pages: 89 - 92
The clinical pharmacology of the adenosine deaminase inhibitor 2′-deoxycoformycin John F. SmythRosanne M. PaineDavid G. Johns Original Articles Pages: 93 - 101
A characterization of the activity of α-1,3,5-triglycidyl-s-triazinetrione, a novel antineoplastic compound Federico SpreaficoGhanem AtassiDonatella Boschetti Original Articles Pages: 103 - 108
Clinical pharmacology of tamoxifen and N-desmethyltamoxifen in patients with advanced breast cancer Peter WilkinsonGerald RibeiroJohn Patterson Original Articles Pages: 109 - 111
Histopathological studies on antitumor effect of sporamycin Yasuaki KawakuboKanki KomiyamaYasukazu Nishiyama Original Articles Pages: 113 - 118
Early detection of doxorubicin cardiotoxicity by M-mode echocardiography W. MarkiewiczE. RobinsonA. Carter Original Articles Pages: 119 - 125
In vivo effects in mice produced by a 3′-branched homologue of α-2′-deoxythioguanosine G. A. LePageP. A. BanksG. R. Buzzell Original Articles Pages: 127 - 131
